Are Surgeons Collecting Enough Tumor Tissue in Laparoscopic Biopsies for HRD Testing?

International Gynecologic Cancer Society (IGCS) Roundtable Webinar Held on 16 June 2022, the roundtable faculty discussed topics such as the importance of HRD testing, challenges in tumor testing, ways to improve sample quantity and quality as well as the optimal laparoscopic techniques. View the on-demand webinar recording below.

Let’s Talk Patient Aspects of Ovarian Cancer Treatment

The next Myriad Oncology webinar next Monday is focused on ovarian cancer. Dr Thomas Slavin will be joined by the National Ovarian Cancer Coalition! We will hear from their physician leadership and patient advocates. We can discuss all things ovarian cancer and they have some exciting updates to share. Please share the below information with Read More

Psychedelics in Psychiatry

Join Genomind and guest speaker, Dr. Cody Wenthur, as we discuss psychedelic use in psychiatry. Cody Wenthur, PharmD, PhD is Assistant Professor of Pharmacy and Director, Psychoactive Pharmaceutical Investigation MS Program, School of Pharmacy, University of Wisconsin-Madison. He completed training at Purdue, Vanderbilt, and Scripps, which included clinical work in inpatient psychiatric units, mechanistically novel Read More

Fecal Lactoferrin Measurements in Clinical Practice

Intestinal inflammation is a hallmark of the inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn’s disease. These chronic autoimmune GI illnesses affect upwards of 3 million children and adults in the United States. Many of the symptoms in patients with IBD overlap with those observed in patients with irritable bowel syndrome (IBS), a discrete Read More

Management of Attention-Deficit Hyperactivity Disorder with a Focus on Pharmacogenetics

Join Genomind Medical Science Liaisons, Dr. Russell Amato, PhD and Dr. Seema Patel, PharmD, as they present on the management of attention-deficit hyperactivity disorder (ADHD). They discuss various treatment options and associated evidence, as well as highlight pharmacogenetic considerations in the management of this challenging clinical presentation.